Aleksandrova LR, Wang YT, Phillips AG (2020) Ketamine and its metabolite, (2R,6R)-HNK, restore hippocampal LTP and long-term spatial memory in the Wistar-Kyoto rat model of depression. Mol Brain 13:92. https://doi.org/10.1186/s13041-020-00627-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ardalan M, Wegener G, Rafati AH, Nyengaard JR (2017) S-ketamine rapidly reverses synaptic and vascular deficits of hippocampus in genetic animal model of depression. Int J Neuropsychopharmacol 20(3):247–256. https://doi.org/10.1093/ijnp/pyw098

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai M, Zhu Y, Shanley MR et al (2023) HCN channel inhibitor induces ketamine-like rapid and sustained antidepressant effects in chronic social defeat stress model. Neurobiol Stress 26:100565. https://doi.org/10.1016/j.ynstr.2023.100565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carreno FR, Donegan JJ, Boley AM et al (2016) Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine. Mol Psychiatry 21(9):1298–308. https://doi.org/10.1038/mp.2015.176

Article  CAS  PubMed  Google Scholar 

Chen BK, Denny CA (2023) Weapons of stress reduction: (R,S)-ketamine and its metabolites as prophylactics for the prevention of stress-induced psychiatric disorders. Neuropharmacology 224:109345. https://doi.org/10.1016/j.neuropharm.2022.109345

Article  CAS  PubMed  Google Scholar 

Chen M, Ma S, Liu H et al (2024) Brain region–specific action of ketamine as a rapid antidepressant. Science 385(6709):eado7010. https://doi.org/10.1126/science.ado7010

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Cheng L, Ma J et al (2023) Molecular mechanisms of rapid-acting antidepressants: new perspectives for developing antidepressants. Pharmacol Res 194:106837. https://doi.org/10.1016/j.phrs.2023.106837

Article  CAS  PubMed  Google Scholar 

Cui L, Li S, Wang S et al (2024) Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther 9(1):30. https://doi.org/10.1038/s41392-024-01738-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deyama S, Duman RS (2020) Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine. Pharmacol Biochem Behav 188(January):172837. https://doi.org/10.1016/j.pbb.2019.172837

Article  CAS  PubMed  Google Scholar 

Deyama S, Kaneda K (2023) Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine. Neuropharmacology 224(February):109335. https://doi.org/10.1016/j.neuropharm.2022.109335

Article  CAS  PubMed  Google Scholar 

Donegan JJ, Lodge DJ (2016a) Hippocampal perineuronal nets are required for the sustained antidepressant effect of ketamine. Int J Neuropsychopharmacol 20(4):354–58. https://doi.org/10.1093/ijnp/pyw095

Article  CAS  Google Scholar 

Donegan JJ, Lodge DJ (2016b) Hippocampal perineuronal nets are required for the sustained antidepressant effect of ketamine. Int J Neuropsychopharmacol 20(4):354–58. https://doi.org/10.1093/ijnp/pyw095

Article  CAS  Google Scholar 

Elmeseiny OSA, Müller HK (2024) A molecular perspective on mGluR5 regulation in the antidepressant effect of ketamine. Pharmacol Res 200(February):107081. https://doi.org/10.1016/j.phrs.2024.107081

Article  CAS  PubMed  Google Scholar 

Freitas AE, Feng B, Woo T et al (2024) Planar cell Polarity proteins mediate Ketamine-Induced restoration of glutamatergic synapses in prefrontal cortical neurons in a mouse model for chronic stress. Nat Commun 15(1):4945. https://doi.org/10.1038/s41467-024-48257-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuchikami M, Thomas A, Liu R et al (2015) Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions. Proc Natl Acad Sci U S A 112(26):8106–11. https://doi.org/10.1073/pnas.1414728112

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fukumoto K, Iijima M, Chaki S (2016) The antidepressant effects of an mGlu2/3 receptor antagonist and ketamine require AMPA receptor stimulation in the mPFC and subsequent activation of the 5-HT neurons in the DRN. Neuropsychopharmacology 41(4):1046–56. https://doi.org/10.1038/npp.2015.233

Article  CAS  PubMed  Google Scholar 

Gagne C, Piot A, Brake WG (2021) Depression, estrogens, and neuroinflammation: a preclinical review of ketamine treatment for mood disorders in women. Front Psychiatry 12:797577. https://doi.org/10.3389/fpsyt.2021.797577

Article  PubMed  Google Scholar 

Gerhard DM, Pothula S, Liu R-J et al (2020) GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions. J Clin Invest 130(3):1336–49. https://doi.org/10.1172/JCI130808

Article  CAS  PubMed  PubMed Central  Google Scholar 

Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y (2018) Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol 18(1):222. https://doi.org/10.1186/s12866-018-1373-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golubeva EA, Lavrov MI, Radchenko EV, Palyulin VA (2022) Diversity of AMPA receptor ligands: chemotypes, binding modes, mechanisms of action, and therapeutic effects. Biomolecules 13(1):56. https://doi.org/10.3390/biom13010056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashimoto K (2020) Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine. Biochem Pharmacol 177:113935. https://doi.org/10.1016/j.bcp.2020.113935

Article  CAS  PubMed  Google Scholar 

Hess EM, Riggs LM, Michaelides M, Gould TD (2022) Mechanisms of ketamine and its metabolites as antidepressants. Biochem Pharmacol 197:114892. https://doi.org/10.1016/j.bcp.2021.114892

Article  CAS  PubMed  Google Scholar 

Ho M-F, Zhang C, Zhang L, Li H, Weinshilboum RM (2019) Ketamine and active ketamine metabolites regulate STAT3 and the type I interferon pathway in human microglia: molecular mechanisms linked to the antidepressant effects of ketamine. Front Pharmacol 10:1302. https://doi.org/10.3389/fphar.2019.01302

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Wu Z, Wang D et al (2024) Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine. Mol Psychiatry 29(6):1741–53. https://doi.org/10.1038/s41380-023-02288-5

Article  CAS  PubMed  Google Scholar 

Huang N, Hua D, Zhan G et al (2019) Role of actinobacteria and coriobacteriia in the antidepressant effects of ketamine in an inflammation model of depression. Pharmacol Biochem Behav 176:93–100. https://doi.org/10.1016/j.pbb.2018.12.001

Article  CAS  PubMed  Google Scholar 

Ide S, Ikekubo Y, Mishina M, Hashimoto K, Ikeda K (2019) Cognitive impairment that is induced by (R)-ketamine is abolished in NMDA GluN2D receptor subunit knockout mice. Int J Neuropsychopharmacol 22(7):449–52. https://doi.org/10.1093/ijnp/pyz025

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobson ML, Simmons SC, Wulf HA et al (2020) Protracted effects of ketamine require immediate kappa opioid receptor activation and long-lasting desensitization. FASEB J 34(S1):1–1. https://doi.org/10.1096/fasebj.2020.34.s1.04214

Article